Anaplastic Ependymoma: Clinical Trials

9 trials for Anaplastic Ependymoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 9 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 3, Recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 22Recruiting 1, Terminated 1

Follow Anaplastic Ependymoma: new trials by email Literature Review of Anaplastic Ependymoma trials Research Report on Anaplastic Ependymoma

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
LUTATHERA® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma
Phase 1 / Phase 2RecruitingNationwide Children's Hospital652022-11-212026-11-16
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years, SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years, SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years - Medulloblastoma, Glioblastoma Multiforme
Phase 1Active not recruitingChildren's Oncology Group352022-07-012026-06-02
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor
Phase 1WithdrawnM.D. Anderson Cancer Center2021-01-142024-10-26
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy, Quality-of-Life Assessment, Questionnaire Administration - Anaplastic Ependymoma, Ependymoma
Phase 1RecruitingM.D. Anderson Cancer Center482019-04-012026-11-10
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Gemcitabine, ribociclib, sonidegib - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedSt. Jude Children's Research Hospital682018-03-052024-05-31
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Laboratory Biomarker Analysis, Lapatinib, Lapatinib Ditosylate - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedNational Cancer Institute (NCI)292016-11-072024-11-06
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
Heat Shock Protein Peptide Complex-96 (HSPPC-96), Tumor Resection, Radiation - Glioblastoma Multiforme, Astrocytoma, Grade III
Phase 1TerminatedAnn & Robert H Lurie Children's Hospital of Chicago102016-07-012025-02-18
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
AXL1717 - Glioblastoma, Gliosarcoma
Phase 1 / Phase 2TerminatedRush University Medical Center102012-12-012023-05-22
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
therapeutic allogeneic lymphocytes, aldesleukin, laboratory biomarker analysis - Anaplastic Astrocytoma, Anaplastic Ependymoma
Phase 1CompletedCity of Hope Medical Center62011-03-222026-10-19

Narrower conditions

Ependymoma (9)  ·  Astrocytoma (6)  ·  Glioblastoma (6)  ·  Glioma (5)  ·  Oligodendroglioma (5)  ·  Brain Neoplasms (4)  ·  Medulloblastoma (4)  ·  Gliosarcoma (3)  ·  Meningioma (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Central Nervous System Neoplasms (2)  ·  Choroid Plexus Carcinoma (2)  ·  Diffuse Intrinsic Pontine Glioma (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Rhabdoid Tumor (2)

Broader conditions

Neoplasms by Histologic Type (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Neoplasms, Nerve Tissue (9)  ·  Neuroectodermal Tumors (9)  ·  Neoplasms (8)  ·  Neoplasms, Neuroepithelial (8)  ·  Neoplasms, Germ Cell and Embryonal (7)  ·  Brain Diseases (6)  ·  Central Nervous System Diseases (6)  ·  Neoplasms by Site (6)  ·  Nervous System Diseases (6)  ·  Nervous System Neoplasms (6)  ·  Central Nervous System Neoplasms (4)  ·  Glioma (4)  ·  Meningeal Neoplasms (3)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Antilymphocyte Serum (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Gemcitabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Interleukin-2 (1)  ·  Interleukins (1)  ·  Lapatinib (1)  ·  Linear Energy Transfer (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Nationwide Children's Hospital (1)  ·  Rush University Medical Center (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (8)  ·  Canada (1)

Top investigators

Behnam Badie (1)  ·  Clare Twist, MD (1)  ·  David R Grosshans (1)  ·  Giles W. Robinson, MD (1)  ·  Kris M Mahadeo, MD (1)  ·  Margot Lazow, MD (1)  ·  Robert Aiken, MD (1)  ·  Stewart Goldman, MD (1)  ·  Timothy F Cloughesy (1)

NIH funding

P30CA016672 (1), U01CA137443 (1), U19CA021239 (1), UM1CA081457 (1), UM1CA137443 (1)